Fred Hsu

746 total citations
22 papers, 433 citations indexed

About

Fred Hsu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Fred Hsu has authored 22 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Fred Hsu's work include Brain Metastases and Treatment (10 papers), Meningioma and schwannoma management (8 papers) and Glioma Diagnosis and Treatment (6 papers). Fred Hsu is often cited by papers focused on Brain Metastases and Treatment (10 papers), Meningioma and schwannoma management (8 papers) and Glioma Diagnosis and Treatment (6 papers). Fred Hsu collaborates with scholars based in Canada, Belgium and United States. Fred Hsu's co-authors include Alan Nichol, Alex De Caluwé, Cheryl Ho, David W. Anderson, Ermias Gete, Hannah Carolan, Roy Ma, Richard Lee, Karl F. Otto and Frances Wong and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Proteins Structure Function and Bioinformatics and Protein Science.

In The Last Decade

Fred Hsu

20 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Hsu Canada 11 300 159 150 75 70 22 433
Renate Haselmann Germany 7 212 0.7× 93 0.6× 148 1.0× 40 0.5× 80 1.1× 9 352
Dror Limon Israel 11 166 0.6× 147 0.9× 162 1.1× 36 0.5× 34 0.5× 45 395
Alessandra Mirri Italy 9 159 0.5× 76 0.5× 111 0.7× 40 0.5× 65 0.9× 15 307
J.A. Bogart United States 9 516 1.7× 368 2.3× 173 1.2× 107 1.4× 45 0.6× 18 604
J.P. Bahary Canada 11 202 0.7× 57 0.4× 184 1.2× 82 1.1× 53 0.8× 21 388
Benjamin Movsas United States 7 464 1.5× 240 1.5× 191 1.3× 53 0.7× 60 0.9× 8 554
Petr Burkoň Czechia 10 224 0.7× 87 0.5× 178 1.2× 50 0.7× 55 0.8× 35 348
H. Al-Halabi Canada 8 187 0.6× 121 0.8× 172 1.1× 33 0.4× 48 0.7× 17 427
Isabella Zhang United States 8 255 0.8× 152 1.0× 85 0.6× 37 0.5× 35 0.5× 19 366
M. Soike United States 14 258 0.9× 133 0.8× 115 0.8× 55 0.7× 130 1.9× 52 469

Countries citing papers authored by Fred Hsu

Since Specialization
Citations

This map shows the geographic impact of Fred Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Hsu more than expected).

Fields of papers citing papers by Fred Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Hsu. The network helps show where Fred Hsu may publish in the future.

Co-authorship network of co-authors of Fred Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Hsu. A scholar is included among the top collaborators of Fred Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Hsu. Fred Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jim Zhang Hao, Andrew Lee, Serge Makarenko, et al.. (2025). Population-Based Real-World Outcomes of Post-Operative Adjuvant Brain Cavity Radiotherapy Versus Observation. Current Oncology. 32(6). 345–345.
2.
Sit, Daegan, et al.. (2022). Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC. JTO Clinical and Research Reports. 3(8). 100371–100371. 2 indexed citations
3.
Hsu, Fred, et al.. (2021). Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study. Clinical and Translational Radiation Oncology. 30. 15–18. 5 indexed citations
4.
Fan, Kevin Yijun, Nafisha Lalani, Nathalie LeVasseur, et al.. (2020). Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy. Journal of Neuro-Oncology. 151(2). 231–240. 5 indexed citations
5.
6.
Olson, Robert, Mitchell Liu, Alanah Bergman, et al.. (2018). Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5. BMC Cancer. 18(1). 954–954. 10 indexed citations
8.
Hsu, Fred. (2017). Salvage Stereotactic Radiosurgery for Multiple Brain Recurrences: How Much is Enough?. Cureus. 9(11). e1835–e1835. 2 indexed citations
9.
Lo, Andrea, G. Ayre, Roy Ma, et al.. (2017). Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. International Journal of Radiation Oncology*Biology*Physics. 100(2). 443–451. 17 indexed citations
10.
Hsu, Fred, et al.. (2017). Patterns of Spread and Prognostic Implications of Lung Cancer Metastasis in an Era of Driver Mutations. Current Oncology. 24(4). 228–233. 26 indexed citations
12.
Hsu, Fred, et al.. (2016). EGFR mutation status on brain metastases from non-small cell lung cancer. Lung Cancer. 96. 101–107. 92 indexed citations
13.
Nichol, Alan, Roy Ma, Fred Hsu, et al.. (2015). Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 94(2). 312–321. 40 indexed citations
14.
Hsu, Fred, et al.. (2015). Stereotactic Radiosurgery for Metastases in Eloquent Central Brain Locations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 42(5). 333–337. 3 indexed citations
15.
Hsu, Fred, Sonia Nguyen, Arthur Cheung, et al.. (2013). Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy. Radiotherapy and Oncology. 108(1). 128–131. 8 indexed citations
16.
Chan, Elisa, Fred Hsu, Don Wilson, et al.. (2013). High-Grade Glioma Radiation Therapy Target Volumes and Patterns of Failure Obtained From Magnetic Resonance Imaging and 18F-FDOPA Positron Emission Tomography Delineations From Multiple Observers. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1100–1106. 29 indexed citations
17.
Herbert, Christopher, Vitali Moiseenko, Michael McKenzie, et al.. (2011). Factors Predictive of Symptomatic Radiation Injury After Linear Accelerator-Based Stereotactic Radiosurgery for Intracerebral Arteriovenous Malformations. International Journal of Radiation Oncology*Biology*Physics. 83(3). 872–877. 17 indexed citations
18.
Hsu, Fred, Hannah Carolan, Alan Nichol, et al.. (2009). Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneous Integrated Boost for 1–3 Brain Metastases: A Feasibility Study Using Volumetric Modulated Arc Therapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1480–1485. 94 indexed citations
19.
Bhattacharya, Shibani, Maria Victoria Botuyan, Fred Hsu, et al.. (2002). Characterization of binding‐induced changes in dynamics suggests a model for sequence‐nonspecific binding of ssDNA by replication protein A. Protein Science. 11(10). 2316–2325. 17 indexed citations
20.
Das, Kalyan, Rong Xiao, E. Wahlberg, et al.. (2001). X‐ray crystal structure of MTH938 from Methanobacterium thermoautotrophicum at 2.2 Å resolution reveals a novel tertiary protein fold. Proteins Structure Function and Bioinformatics. 45(4). 486–488. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026